STOCK TITAN

Corpay Form 4 Filings

CPAY NYSE

Every Form 4 that Corpay (CPAY) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CPAY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CPAY filings page.

Rhea-AI Summary

CORPAY, INC. (CPAY) reported that officer Alan King, Group President Intl Vehicle Payments, sold 3,805 shares of Common Stock on 2026-08-21 in a market transaction at a weighted average price of $416.6085 per share. After this sale, King directly holds 20,732 shares of Corpay common stock. The sale was executed through multiple open-market trades within a $416.50–$417.31 price range, reported in aggregate within a one-dollar band.

Rhea-AI Summary

CORPAY, INC. (CPAY) reported insider transactions by CEO and Chairman Ronald Clarke involving option exercises and share sales. On August 21, 2026, he exercised 450,000 Employee Stock Options with a $150.7400 exercise price, acquiring 450,000 shares of Common Stock, and had 200,000 options remaining after the exercise. In connection with this exercise, 290,043 shares of Common Stock were delivered or withheld at $417.1300 per share for payment of exercise price or tax liability under Rule 16b-3. On August 24–25, 2026, he conducted open-market sales totaling 213,860 shares of Common Stock in multiple trades, at weighted average prices generally between about $409 and $420 per share, each sale reported with one-dollar price ranges.

Rhea-AI Summary

CORPAY, INC. (CPAY) director Steven T. Stull reported open-market sales of an aggregate 2,357 shares of Common Stock on August 20, 2026, in three blocks at weighted average prices of $412.91, $413.67, and $414.62, each with disclosed one-dollar price ranges. He also reports indirect holdings of 6,247 shares held by funds over which he has shared voting power and for which he disclaims beneficial ownership beyond his pecuniary interest. The transactions were not reported as pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

For CORPAY, INC. (CPAY), Group President International Vehicle Payments Alan King exercised 18,423 employee stock options on 2026-08-20 at an exercise price of $196.18 per share, acquiring the same number of common shares. On the same day he sold an aggregate of 18,423 common shares in multiple open-market trades, reported in three lines with weighted average prices of $414.0779 (range $413.51–$414.51), $415.0733 (range $414.53–$415.50) and $415.7031 (range $415.59–$416.265). The option grant, originally exercisable from 2021-03-27 and expiring 2030-03-27, is reported with 0 options remaining from this block after the exercise.

Rhea-AI Summary

For CORPAY, INC. (CPAY), director Steven T. Stull reported multiple open-market sales of common stock on August 18–19, 2026, totaling 4,643 shares, at prices generally around $409–$412 per share, as reflected by weighted-average sale prices within specified one-dollar ranges.

The Form 4 also reports an indirect holding of 6,247 shares held "by Funds," for which Stull has shared voting power and may be deemed to beneficially own only to the extent of his pecuniary interest. The Rule 10b5-1 checkbox is not marked as being pursuant to a trading plan.

Rhea-AI Summary

CORPAY, INC. (CPAY) reported insider transactions by officer Alan King, Group President Intl Vehicle Payments. On August 14 and 18, 2026, King exercised 25,785 employee stock options at exercise prices of $261.07, $231.70, and $196.18 per share, receiving an equal number of common shares.

Across those dates, he then sold 25,785 common shares in open-market transactions at weighted average prices around $410–$420 per share, as detailed in footnotes that provide one-dollar price ranges for each sale batch.

Rhea-AI Summary

Corpay, Inc. director Joseph W. Farrelly reported selling a total of 5,300 shares of Common Stock in open-market transactions on August 12–13, 2026. The sales included 1,800 shares at a weighted average price of $405.09 (price range $405–$405.73), 1,749 shares at $410.02 (range $410–$410.12), and 1,751 shares at $415.03 (range $415–$415.28). Each sale was executed through a broker-dealer, with prices aggregated into one-dollar ranges.

Rhea-AI Summary

Netto Armando Lins reported acquisition or exercise transactions in this Form 4 filing.

CORPAY, INC. granted Group President Brazil & US Vehicle Payments Armando Lins Netto three tranches of performance-based restricted stock units totaling 28,213 units. Each unit represents a contingent right to one share of CPAY common stock. The tranches cover 9,405, 9,404 and 9,404 units that may be earned only if the CPAY share price equals or exceeds $425.00, $450.00 and $475.00, respectively, on five separate trading days before August 31, 2028, and remain subject to the company’s equity compensation plan and award agreement terms.

Rhea-AI Summary

Clarke Ronald reported acquisition or exercise transactions in this Form 4 filing.

Corpay, Inc. reported that CEO and Chairman Ronald Clarke received grants of three tranches of 100,000 performance-based restricted stock units, each settled in common stock. Each tranche is earned only if CPAY’s closing price equals or exceeds $425, $450, or $475 on five separate trading days before August 31, 2028, with vesting of earned units subject to the company’s equity compensation plan and related award agreements.

Rhea-AI Summary

Corpay CFO Peter Walker reported compensation-related equity activity on July 15, 2026. The company withheld a total of 1,660 shares of common stock at $356.16 per share to cover tax liabilities on vesting awards. He also received 568 vested performance-based shares and a new 938-share performance-based restricted stock award that will vest in thirds through 2028, subject to continued employment; no open-market trades were reported.

Rhea-AI Summary

Corpay, Inc. executive Armando Lins reported an exercise-and-sell transaction in company stock. On June 15, 2026, he exercised employee stock options to acquire a total of 70,476 shares of Corpay common stock and, on the same date, completed an open-market sale of 70,476 common shares at an average price of $352.1308 per share.

Following these transactions, Lins holds 11,274 Corpay common shares directly. The derivative summary in this filing shows no remaining employee stock options, indicating that the reported option positions were fully exercised.

Rhea-AI Summary

Corpay, Inc. director Steven T. Stull reported an open-market sale of 1,000 shares of Common Stock at $360.78 per share on June 2, 2026. After this transaction, he directly holds 28,241 Corpay shares. The filing also notes 6,247 shares held indirectly "by Funds," over which he has shared voting power through Advantage Capital Financial Company, LLC and related entities, while disclaiming beneficial ownership beyond his pecuniary interest.

Rhea-AI Summary

CORPAY, INC. Group President Armando Lins Netto sold 4,560 shares of Common Stock in an open-market transaction at $351.6025 per share. After this sale, he directly holds 11,274 shares, so the transaction reduces but does not eliminate his personal equity stake.

Rhea-AI Summary

Corpay, Inc. executive Armando Lins Netto reported selling 17,201 shares of Common Stock in open-market transactions. The sales occurred over three days, with 418 shares sold on May 27, 14,089 shares on May 28, and 2,694 shares on May 29 at prices around $355–$357 per share. After these transactions, he directly holds 15,834 Corpay shares.

Rhea-AI Summary

CORPAY, INC. CEO and Chairman Ronald Clarke reported option-related share movements. He exercised 100,000 shares of common stock through employee stock options at $150.74 per share, converting a derivative position into directly held stock.

To cover the tax liability and exercise price, 68,150 shares of common stock were withheld at $352.37 per share, classified as a tax-withholding disposition under Rule 16b-3 rather than an open-market sale. After these transactions, Clarke directly owns 2,408,233 shares of Corpay common stock and retains 650,000 employee stock options exercisable at $150.74 per share that are scheduled to expire on January 25, 2027.

Rhea-AI Summary

CORPAY, INC. CEO and Chairman Ronald Clarke exercised employee stock options and settled related obligations using company shares. He exercised 100,000 shares of Common Stock at $150.74 per share, then 68,487 shares were withheld at $347.46 per share to cover tax liability and exercise price under Rule 16b-3. Following these compensation-related transactions, Clarke directly holds 2,376,383 shares of Common Stock.

Rhea-AI Summary

Corpay, Inc. Chief Accounting Officer Alissa B. Vickery reported compensation-related stock transactions, not open-market trades. On April 22, 2026, she received two performance-based restricted stock awards totaling 1,152 common shares, recorded at $0.00 per share as compensation grants.

On the same date, 378 shares were withheld at $329.93 per share to cover tax liabilities associated with these vesting awards under Rule 16b-3. After these grant and tax-withholding dispositions, she directly owns 2,787 shares of Corpay common stock.

Rhea-AI Summary

Corpay, Inc. Group President International Vehicle Payments Alan King reported an amended stock award and related tax withholding. He received 683 shares of common stock as performance-based restricted stock vesting, and 250 shares were withheld at $337.12 per share to cover tax obligations.

After these adjustments, the filing shows 23,356 shares held directly, with a footnote indicating an updated figure of 24,537 shares inclusive of other disclosed activity. The disposition is strictly for tax payment and does not reflect an open-market sale.

Rhea-AI Summary

Corpay, Inc. executive Armando Lins Netto reported a routine tax-related share disposition. On the vesting of equity under Rule 16b-3, 760 shares of Common Stock were withheld at $310.22 per share to cover tax liabilities. After this withholding, he directly holds 33,035 shares, so the transaction affects only a small portion of his position and does not represent an open-market sale.

Rhea-AI Summary

Corpay, Inc. executive Armando Lins Netto reported an amended stock award and related tax withholding. On 2026-02-14, he acquired 925 shares of common stock at $0.0000 per share as a grant or award, bringing his holdings at that point to 34,206 shares directly owned.

The filing also shows 411 shares of common stock withheld at $337.1200 per share to satisfy tax liabilities tied to the vesting, leaving him with 33,795 shares directly owned afterward. Footnotes explain this Form 4/A amends previously reported figures, changing the vesting amount from 1,021 to 925 shares and tax-withheld shares from 454 to 411.

Rhea-AI Summary

Corpay, Inc. reported that Chief Accounting Officer Alissa B. Vickery acquired an award of 1,991 employee stock options on March 5, 2026. These options were granted to her as part of her compensation.

The options vest in four equal 25% installments on March 5 of 2027, 2028, 2029 and 2030, provided she remains employed with the company on each vesting date.

Rhea-AI Summary

Walker Peter reported acquisition or exercise transactions in this Form 4 filing.

Corpay, Inc. Chief Financial Officer Peter Walker reported equity awards on February 24, 2026. He received 11,467 Employee Stock Options and a grant of 1,772 shares of Common Stock, both at a stated price of $0.00 per share as compensation.

The restricted stock will vest in three equal installments of 33% on February 24, 2027, 2028 and 2029, if he remains employed on each vesting date. The options will vest 25% per year on February 24, 2027, 2028, 2029 and 2030, also conditioned on continued employment.

Rhea-AI Summary

Corpay, Inc. reported that executive Alan King, Group President of International Vehicle Payments, received new equity awards on February 24, 2026. He was granted 7,645 Employee Stock Options at an exercise price of $0.0000 per share and 1,181 shares of Common Stock as a grant or award.

The restricted stock will vest in three equal installments of 33% on February 24, 2027, 2028 and 2029, subject to his continued employment on each vesting date. The options will vest in four equal installments of 25% on February 24, 2027, 2028, 2029 and 2030, also contingent on continued employment.

Rhea-AI Summary

Throop Gerald C reported acquisition or exercise transactions in this Form 4 filing.

Corpay, Inc. director Gerald C. Throop received an award of 886 shares of common stock for 2026 director service, structured as restricted stock that vests on February 24, 2027. After this grant, he directly holds a total of 2,435 common shares.

Rhea-AI Summary

CORPAY, INC. director Steven T. Stull received a grant of stock options covering 2,867 derivative securities as compensation for 2026 director service. The award was made on February 24, 2026 at an exercise price reported as $0.0000 per option.

According to the disclosure, these options vest on February 24, 2027, meaning they become exercisable on that date. After this grant, Stull’s directly held stock option balance reported in this line is 2,867 options.

Rhea-AI Summary

Sloan Jeffrey Steven reported acquisition or exercise transactions in this Form 4 filing.

CORPAY, INC. director Jeffrey Steven Sloan received an award of 886 shares of common stock as a grant for 2026 director service. The restricted stock was granted at no cost and is scheduled to vest on February 24, 2027. After this award, Sloan directly holds 13,360 common shares.

Rhea-AI Summary

Corpay, Inc. director Moddelmog receives stock award. Director Hala G. Moddelmog acquired 886 shares of Corpay common stock on a grant or award basis at no cost on February 24, 2026. This restricted stock award relates to 2026 director service and will vest on February 24, 2027, bringing her direct holdings to 8,500 shares.

Rhea-AI Summary

Macchia Richard reported acquisition or exercise transactions in this Form 4 filing.

CORPAY, INC. director Richard Macchia received a grant of 886 shares of common stock as a restricted stock award for 2026 director service. These shares vest on February 24, 2027. After this award, his directly owned common stock holdings total 13,681 shares.

Rhea-AI Summary

Jones Archie L Jr reported acquisition or exercise transactions in this Form 4 filing.

Corpay, Inc. director Archie L. Jones Jr. received a grant of 886 shares of common stock as a restricted stock award for his 2026 director service. The award was granted at no cash purchase price and will vest on February 24, 2027. Following this grant, Jones directly holds 4,830 shares of Corpay common stock.

Rhea-AI Summary

Corpay, Inc. director Thomas M. Hagerty received a grant of stock options covering 2,867 shares on February 24, 2026. The options were awarded as compensation for 2026 director service, with an exercise price of $0.00 per share, and they vest on February 24, 2027. Following this grant, Hagerty holds 2,867 stock options directly.

Rhea-AI Summary

Corpay, Inc. director Rahul Gupta reported receiving a grant of common stock as part of his 2026 board compensation. He acquired 886 shares of common stock at a price of $0.00 per share through a restricted stock award for 2026 director service. After this award, his directly owned common stock holdings total 3,599 shares. The restricted stock is scheduled to vest on February 24, 2027, meaning the shares are subject to service-based vesting conditions until that date.

Rhea-AI Summary

Farrelly Joseph W reported acquisition or exercise transactions in this Form 4 filing.

Corpay, Inc. director Joseph W. Farrelly received a grant of 886 shares of common stock on February 24, 2026 as a restricted stock award for 2026 director service. According to the disclosure, these shares vest on February 24, 2027, increasing his directly held stake to 12,212 shares.

Rhea-AI Summary

BEXIGA ANNABELLE G reported acquisition or exercise transactions in this Form 4 filing.

Corpay, Inc. director Annabelle G. Bexiga received an equity grant of 886 shares of common stock. The award is restricted stock for 2026 director service and will vest on 2/24/2027. Following this grant, she directly owns a total of 4,326 Corpay common shares.

Rhea-AI Summary

Corpay, Inc. executive Armando Lins Netto reported a mix of stock awards and tax-related share withholdings in common stock. On February 14, 2026, he received several performance-based restricted stock awards and had shares automatically withheld at $337.1200 per share to cover tax liabilities tied to vesting, rather than selling shares in the open market.

Rhea-AI Summary

Corpay, Inc. executive Alan King reported a mix of stock awards and tax-related share dispositions in company common stock. On February 14, 2026, he received several grant or award acquisitions of common stock at $0.00 per share and, in separate transactions, delivered shares back to the company at $337.12 per share to satisfy tax liabilities tied to vesting performance-based restricted stock. All reported holdings are shown as directly owned.

Rhea-AI Summary

Corpay, Inc. Chief Financial Officer Peter Walker reported two stock transactions involving company common shares. He acquired 1,252 shares at a stated price of $0.00 per share as a grant/award tied to the vesting of performance-based restricted stock.

To cover related tax obligations on this vesting, 318 shares were disposed of through tax withholding at $337.12 per share, rather than an open-market sale. After these transactions, Walker directly held 4,924 shares of Corpay common stock.

Rhea-AI Summary

Corpay, Inc. reported that Chief Accounting Officer Alissa B. Vickery had 167 shares of common stock withheld on February 14, 2026 to cover tax liabilities associated with vesting equity awards. The shares were valued at $337.12 per share, and she now directly holds 2,013 shares of Corpay common stock.

Rhea-AI Summary

Corpay, Inc. CEO and Chairman Ronald Clarke reported several equity-related transactions in Corpay common stock. On February 14, 2026, he received a grant or award of 6,630 shares of common stock at a stated price of $0.00 per share, increasing his direct holdings.

On the same date, he had three separate tax-withholding dispositions in connection with equity vesting: 2,920 shares, 3,215 shares, and 2,953 shares, each priced at $337.12 per share, used to satisfy tax liabilities incident to vesting under Rule 16b-3.

Rhea-AI Summary

Corpay, Inc. director Jeffrey Steven Sloan reported an open-market sale of 3,600 shares of Common Stock. The transaction took place at an average price of $343.6154 per share. After this sale, Sloan’s directly held ownership stands at 12,474 shares of Corpay common stock.

Rhea-AI Summary

Corpay, Inc. director Hala G. Moddelmog reported a tax-related share disposition. On February 14, 2026, 216 shares of common stock were withheld at $337.12 per share to cover tax liabilities tied to vesting under Rule 16b-3. After this withholding transaction, Moddelmog directly owns 7,614 shares of Corpay common stock.

Rhea-AI Summary

Corpay, Inc. director Richard Macchia reported a tax-related share disposition. On the reported date, 216 shares of common stock were withheld at a price of $337.12 per share to cover tax liabilities tied to vesting of equity awarded under Rule 16b-3. After this tax-withholding disposition, Macchia’s directly owned holdings total 12,795 shares of Corpay common stock.

Rhea-AI Summary

Corpay, Inc. director Archie L. Jones Jr. reported a small tax-related share disposition. On the transaction date, 216 shares of common stock were withheld at $337.12 per share to cover tax liabilities tied to vesting equity. After this withholding, he directly owns 3,944 common shares.

Rhea-AI Summary

CORPAY, INC. director Rahul Gupta reported a Form 4 showing a tax-related share disposition. On the reported date, 256 shares of common stock were withheld at a price of $337.12 per share to cover tax obligations tied to vesting under Rule 16b-3. After this transaction, Gupta directly owned 2,713 common shares.

Rhea-AI Summary

Corpay, Inc. director Annabelle G. Bexiga reported a small share disposition related to equity compensation taxes. On the transaction date, 175 shares of common stock were withheld at $337.12 per share to satisfy a tax liability upon vesting of a stock-based award. After this tax-withholding disposition, she directly owned 3,440 shares of Corpay common stock.

Rhea-AI Summary

Corpay, Inc. director Gerald C. Throop reported a tax-related share disposition. On February 14, 2026, 436 shares of Corpay common stock were disposed of at $337.12 per share to satisfy tax withholding obligations upon vesting of an equity award. This was a tax-withholding transaction under Rule 16b-3, not an open-market trade. After this event, Throop directly held 1,549 Corpay common shares.

Rhea-AI Summary

Corpay, Inc. insider activity: Chief Accounting Officer Alissa B. Vickery exercised stock options for 4,424 shares of common stock at $224.99 per share on 02/10/2026.

To cover taxes and exercise costs, 3,448 shares were withheld, and she sold 976 and 725 shares at prices of $358.91 and $358.305. After these transactions, she directly owned 2,180 common shares.

Rhea-AI Summary

Corpay, Inc. officer Netto Armando Lins, GroupPresident Brazil&USVehPmt, reported a routine share withholding related to taxes. On 01/23/2026, 1,350 shares of common stock were withheld at $327.14 per share to cover tax liabilities on a vesting award under Rule 16b-3.

After this transaction, he beneficially owns 32,019 Corpay common shares, held directly. This event reflects tax management on equity compensation rather than an open-market sale.

Rhea-AI Summary

Corpay, Inc. officer Alan King reported a routine share withholding to cover taxes on vested stock. On January 23, 2026, 490 shares of Corpay common stock were withheld at a price of $327.14 per share, as payment of tax liability tied to a vesting award under Rule 16b-3.

Following this transaction, King directly beneficially owned 21,598 shares of Corpay common stock. The filing reflects administrative tax settlement related to equity compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Corpay, Inc. Chief Accounting Officer Alissa B. Vickery reported a small share withholding to cover taxes on vested equity. On 01/24/2026, 69 shares of Corpay common stock were withheld at a price of $320.52 per share, as a payment of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3. Following this tax withholding, Vickery beneficially owns 2,905 shares of Corpay common stock directly.

Rhea-AI Summary

Corpay, Inc. director reports open-market stock purchase

A director of Corpay, Inc. reported buying 8,000 shares of the company’s common stock on 12/12/2025. The transaction, coded "P" for purchase, was executed at a price of $314.98 per share. Following this transaction, the director directly owns 29,241 shares of Corpay common stock.

The filing also notes indirect beneficial ownership of an additional 6,247 shares held by certain funds. The director has shared voting power over those fund-held shares and may be deemed to beneficially own them, but disclaims beneficial ownership except to the extent of any pecuniary interest.